Categories AlphaGraphs, Earnings, Industrials

Navistar’s Q4 results beat market estimates

Navistar International Corporation (NAV) surpassed market expectations on both revenue and earnings for the fourth quarter of 2018. The stock was up 9% in premarket trade on Tuesday.

Revenues grew 28% to $3.3 billion versus the same period a year ago, driven mainly by a 45% increase in the company’s core volumes, which represents sales of Class 6-8 trucks and buses in the US and Canada.

Navistar fourth quarter 2018 earnings infographic
Navistar Q4 2018 Earnings Infographic

Net income was $188 million, or $1.89 per share, compared to $135 million, or $1.36 per share, in the prior-year period.

During the quarter, Navistar launched the International CV Series line of Class 4/5 trucks and saw a year-over-year growth of 2.5 share points in heavy retail market share, which was attributable to strong sales of the International LT Series on-highway truck and the 12.4-liter A26 engine. Navistar’s IC Bus school buses also improved retail share by 1.3 share points.

Earnings Preview: Strong truck demand expected to fuel Navistar’s Q4 growth

Earlier this month, Navistar announced the sale of a majority interest in its Navistar Defense business to affiliates of Cerberus Capital Management. The agreement includes a long-term supply agreement for commercial parts and chassis. The transaction is expected to close in the first quarter of 2019, following which Cerberus will become a 70% owner and Navistar will remain a 30% owner.

For the full year of 2019, revenues are expected to be between $10.75 billion and $11.25 billion. Industry retail deliveries of Class 6-8 trucks and buses in the US and Canada are forecast to be 395,000 to 425,000 units, with Class 8 retail deliveries of 265,000 to 295,000 units. After completing the partial sale of Navistar Defense, the company will update its 2019 guidance.

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top